METiS Pharmaceuticals Technology has officially announced the completion of an Angel+ round and Pre-A round of financing of more than RMB100 million yuan.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
